4th Quarter - Report
CHAMBER HILL STRATEGIES for GLAXOSMITHKLINE, INC.
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; S.1871, the SGR Repeal and Medicare Beneficiary Access Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL | Health Policy Advisor, Sen. Finance Committee |
| MICHAELA SIMS | Legislative Counsel, Sen. Bob Kerrey |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.